In English
NIDA

NIDA Notes Articles: Investigaciones sobre los tratamientos

NIDA Notes Category Graphic

Few Teens With Prescription Opioid Use Disorders Receive Treatment

julio del 2012

Fewer than 12 percent of adolescents who meet diagnostic criteria for prescription opioid abuse or dependence receive any treatment, according to an analysis of data from the 2005 to 2008 National Survey on Drug Use and Health. The most common reason the adolescents gave for not receiving treatment was their lack of perceived need for it.

NIDA Notes Category Graphic

Intervention Boosts Treatment Participation, Abstinence Among Depressed Women

julio del 2012
Intensive case management was more effective in increasing treatment engagement and reducing alcohol consumption among depressed participants than among those who were not depressed, according to a followup analysis of a substance abuse treatment study involving women on welfare.

NIDA Notes Category Graphic

Training Gaps for Evidence-Based Practices

julio del 2012

Ninety percent of privately funded substance abuse treatment programs in the United States offer cognitive behavioral therapy (CBT)...

NIDA Notes Category Graphic

More Convenient Preparations of Buprenorphine Pass Test

julio del 2012
Soluble-film preparations of buprenorphine suppressed heroin abusers’ withdrawal symptoms with no serious side effects in a recent clinical trial. They dissolved more rapidly in the mouth than the pill form of the medication, providing faster relief.

NIDA Notes Category Graphic

The Present and Promise of mHealth

julio del 2012
NIDA researchers have developed a computer program that motivates and encourages treatment-seeking when an individual is in a primary care physician’s waiting room. Users of the program, called Video Doctor, enter information on a portable device and receive feedback about health risks related to their drug abuse, along with advice, immediately prior to seeing their physician.

NIDA Notes Category Graphic

Buprenorphine During Pregnancy Reduces Neonate Distress

julio del 2012

Sublingual buprenorphine is a safe and effective alternative to methadone for treating opioid dependence during pregnancy, finds the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a NIDA-supported clinical trial. Women who received either medication had similar pregnancy and birth outcomes, but infants born to women who received buprenorphine had milder symptoms of neonatal opioid withdrawal.

NIDA Notes Category Graphic

Dr. David Jentsch Receives the 2011 Waletzky Memorial Award

julio del 2012
Dr. J. David Jentsch is the recipient of the 2011 Jacob P. Waletzky Memorial Award for Innovative Research in Drug Addiction and Alcoholism. Dr. Jentsch and colleagues at the University of California, Los Angeles, are studying genetic and neurochemical factors that influence individual differences in inhibitory control.

NIDA Notes Category Graphic

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

abril del 2012
Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

NIDA Notes Category Graphic

Women and Sex/Gender Differences Research Program

abril del 2012
NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

NIDA Notes Category Graphic

Research Focuses on Groups With High Smoking Rates

abril del 2012
Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas